CGT
JUNO

Capital Guardian Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital Guardian Trust’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-890,585
Closed -$40.7M – 249
2017
Q4 		$40.7M Buy
890,585
+56,890
+7% +$2.84M 0.58% 70
2017
Q3 		$37.4M Buy
+833,695
New +$28.4M 0.65% 63

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capital Guardian Trust's JUNO Position: Q1 2018 in Review

Capital Guardian Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 890,585 shares — an estimated $40.7M sold.

Capital Guardian Trust first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $40.7M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital Guardian Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital Guardian Trust sold 890,585 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $40.7M.
  • Capital Guardian Trust first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital Guardian Trust's Juno Therapeutics, Inc. position peaked at $40.7M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital Guardian Trust's 13F filing for Q1 2018, filed 15 May 2018.